RecruitingNCT02936791

Early PKD Observational Cohort Study


Sponsor

University of Kansas Medical Center

Enrollment

250 participants

Start Date

Apr 1, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

This observational study will collect blood and urine and clinical information from individuals with early-stages of polycystic kidney disease (PKD), their unaffected siblings and normal volunteers to create a biobank, also called a biorepository. The long-term goal is to develop new knowledge on biological markers or biomarkers that indicate changes in the disease progression. An understanding of biomarkers for early renal cyst growth will benefit PKD patients as new therapies are being developed and tested.


Eligibility

Min Age: 4 YearsMax Age: 35 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with polycystic kidney disease. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 4 Years to 35 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(3)

University of Chicago

Chicago, Illinois, United States

University of Kansas Medical Center

Kansas City, Kansas, United States

Children's Mercy Hospital

Kansas City, Missouri, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02936791


Related Trials